Bortezomib will boost the stage or effect of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Improved flibanserin adverse consequences could manifest if coadministered with a number of weak CYP3A4 inhibitors. fluconazole will enhance the level or influence of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use https://biib02122109.blogitright.com/26868878/new-step-by-step-map-for-lenvatinib